Brief: Replimune Provides Update Following Type A Meeting With FDA
18/09/2025 14:20
Sept 18 (Reuters) - Replimune Group Inc REPL.O: REPLIMUNE PROVIDES UPDATE FOLLOWING TYPE A MEETING WITH FDA REPLIMUNE GROUP INC - EVALUATING FDA FEEDBACK, PATH FORWARD UNDETERMINED Source text: ID:nGNX8B66NN Further company coverage: REPL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replimune
See all newsTrump picks White House adviser Heidi Overton to run FDA, source says (updated)
Brief: Replimune Group, Inc. Files For Mixed Shelf Size Not Disclosed
Brief: Replimune Reports Fiscal First Quarter 2027 Financial Results And Provides Corporate Update
Replimune Q1 net loss narrows as expenses decline
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly